Condition

Cannabis Dependence

ClinicalTrials.gov condition label

Clinical trials7

Recruiting2

Common interventions7

Lead sponsors shown7

Clinical trials

7 shown

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis UseNCT05445180 · 2022-04-21

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) ScanningNCT01730781 · 2010-07-01

Clozapine for Cannabis Use in SchizophreniaNCT01639872 · 2013-05-01

The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced PsychosisNCT01565174 · 2012-10-01

Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With SchizophreniaNCT01598896 · 2012-05-01

Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in IsraelNCT01510015 · 2012-01-01

Risk Perception in Drug-Dependent Adults With and Without SchizophreniaNCT01031563 · 2009-08-18

Common interventions

RisperidoneDRUG2 [11-C]OMARRADIATION1 ClonidineDRUG1 ClozapineDRUG1 Contingency managementBEHAVIORAL1 DronabinolDRUG1 PlaceboDRUG1

Leading sponsors

Dartmouth-Hitchcock Medical Center1 Douglas Mental Health University Institute1 Hadassah Medical Organization1 Mclean Hospital1 National Institute on Drug Abuse (NIDA)1 Tel-Aviv Sourasky Medical Center1 Yale University1

Trial status mix

COMPLETED2

RECRUITING2

UNKNOWN2

TERMINATED1

Phase mix

NA2

PHASE21

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.